News for Healthier Living

Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-negative breast cancer (TNBC), one of the most aggressive and hard-to-treat forms of breast cancer.

August 21, 2025


August 21 2025

August 20 2025

August 19 2025

August 18 2025

August 17 2025

August 16 2025

August 15 2025

August 14 2025

August 13 2025

August 12 2025

August 11 2025

August 10 2025

August 9 2025

August 8 2025

August 7 2025